Round table 2
Mentoring matters: importance of female mentorship in neurorehabilitation
08:30 – 10:00
Plenary session 3
10:15 – 11:15
Round table 3
Ethical considerations for the use of artificial intelligence in healthcare, who will be responsible?
11:30 – 13:00
Plenary session 4
14:30 – 15:30
WFNR presidential symposium
WHOiGAP implementation and brain health
15:45 – 17:15
Presidential symposium roundtable
Where do we go next?
17:30 – 18:30
General assembly
18:45 – 19:45
Symposium 16
Connectome based neuromodulation coupled with intensive training to induce prehabilitation before neurosurgery: one step further in oncological neurorehabilitation
Symposium 21
Multimodal interventions for cognitive neurorehabilitation in older adults at risk of dementia
Symposium 26
Novel methods of rehabilitation in multiple sclerosis
Short symposium 1
Heads up on concussion! Mechanisms, symptom profiles, assessments, treatments and person-centered rehabilitation of persistent symptoms
Symposium 17
Neurogenic supine hypertension and cardiovascular autonomic dysfunction in patients with Parkinson's disease
Symposium 22
Recent Cochrane systematic reviews - lessons to be learnt for stroke rehabilitation
Joint WFNR-Cochrane Rehabilitation Symposium
Symposium 27
From the bedside to home, robotics and technology for rehabilitation
Symposium 18
Behavioral stroke biomarkers: a window into recovery variability
Symposium 23
New challenges in pediatric neurorehabilitation
Industry sponsored workshop
Neuroskin: an AI-powered neuroprosthesis for gait rehabilitation after stroke
13:15 – 14:00
Short symposium 3
Tele-neurorehabilitation for people in the chronic stages of neurological disorders: addressing the gap in research and treatment
Symposium 19
Spatial neglect care from neuroscience to occupational therapy practice using prism adaptation treatment
Symposium 24
Changing rehab needs of persons with multiple sclerosis
Submitted by Multiple Sclerosis SIG WFNR (In Association with RIMS Europe and Developing World Forum WFNR)
Symposium 29
Global disease burden and recent advances in management of Spinal Muscular Atrophy
Short symposium 4
Dysphagia in obstructive sleep apnea and associated neurological conditions and implications for neurorehabilitation
Joint symposium 1
ISPRM joint symposium
Joint symposium 2
WFN joint symposium
Oral communications 9
13:15 – 14:15
Career development session
15:45 – 17:45
Best of orals 1
Symposium 25
Neuromodulation for the treatment of acquired and developmental brain injury across the lifespan
Oral communications 10
Best of orals 2
Short symposium 5
Patient-oriented approaches for research and clinical practice in brain injury rehabilitation
Symposium 20
Neuromodulation and neural plasticity
Hands-on training in ultrasound-guided injection of botulinum neurotoxin type A for neurorehabilitation of the upper limb and neck muscles
11:30 – 14:00
Developing world forum 4
Alternate medicine in neurorehabilitation
Oral communications 11
Poster self-study
10:15 – 13:15
Poster walk 2
14:15 – 18:30
SIG 11
Clinical Pathways
SIG 13
Spinal Cord Injury
WFNR mentor team meeting
13:00 – 14:00
SIG 15
Neuropathic Pain
SIG 17
Telerehabilitation
SIG 12
Developing World Forum
SIG 14
Rehabilitation for Movement Disorders
SIG 20
Paediatric Neurorehabilitation
SIG 16
Neurological Conditions and Driving
NeuroPalliative Care
Friday, 24 May